SE9704103L - Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil - Google Patents

Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil

Info

Publication number
SE9704103L
SE9704103L SE9704103A SE9704103A SE9704103L SE 9704103 L SE9704103 L SE 9704103L SE 9704103 A SE9704103 A SE 9704103A SE 9704103 A SE9704103 A SE 9704103A SE 9704103 L SE9704103 L SE 9704103L
Authority
SE
Sweden
Prior art keywords
fentanyl
sufentanil
electrotransport
accordance
concentration
Prior art date
Application number
SE9704103A
Other languages
Unknown language ( )
English (en)
Other versions
SE9704103D0 (sv
SE521220C2 (sv
Inventor
Joseph B Phipps
Mary Southam
Keith J Bernstein
Henk Noorduin
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23848034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9704103(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of SE9704103D0 publication Critical patent/SE9704103D0/sv
Publication of SE9704103L publication Critical patent/SE9704103L/sv
Publication of SE521220C2 publication Critical patent/SE521220C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
SE9704103A 1995-06-05 1997-11-10 Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil SE521220C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/465,492 US6881208B1 (en) 1995-06-05 1995-06-05 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
PCT/US1996/009264 WO1996039224A1 (en) 1995-06-05 1996-06-05 Device for transdermal electrotransport delivery of fentanyl and sufentanil

Publications (3)

Publication Number Publication Date
SE9704103D0 SE9704103D0 (sv) 1997-11-10
SE9704103L true SE9704103L (sv) 1997-11-10
SE521220C2 SE521220C2 (sv) 2003-10-14

Family

ID=23848034

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704103A SE521220C2 (sv) 1995-06-05 1997-11-10 Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil

Country Status (20)

Country Link
US (3) US6881208B1 (sv)
JP (3) JPH11506684A (sv)
KR (1) KR100431364B1 (sv)
CN (1) CN1118308C (sv)
AT (1) AT409088B (sv)
AU (1) AU695465B2 (sv)
BE (1) BE1009505A3 (sv)
BR (1) BR9609137B1 (sv)
CA (2) CA2219736C (sv)
CH (1) CH690751A5 (sv)
DE (1) DE19681420B4 (sv)
FR (1) FR2736837B1 (sv)
GB (1) GB2317115B (sv)
GR (1) GR1002982B (sv)
IE (1) IE960374A1 (sv)
IT (1) IT1285387B1 (sv)
NL (1) NL1003274C2 (sv)
SE (1) SE521220C2 (sv)
WO (1) WO1996039224A1 (sv)
ZA (1) ZA964658B (sv)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
DK1051220T3 (da) 1998-01-28 2005-02-14 Alza Corp Elektrotransportelektrodesamling med lavere begyndelsesmodstand
US6858018B1 (en) 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
JP4321966B2 (ja) 1998-11-02 2009-08-26 アルザ・コーポレーション 適合性抗微生物剤を含有する電気輸送式デバイス
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6496727B1 (en) * 2000-05-31 2002-12-17 Becton, Dickinson And Company Medicament-loaded transdermal reservoir and method for its formation
NZ524396A (en) 2000-07-31 2003-09-26 Nycomed Danmark As Fentanyl composition for nasal administration comprising water as a solvent
EP1317306B1 (en) * 2000-09-11 2005-04-20 Alza Corporation Transdermal electrotransport device and method for manufacturing same
NZ528750A (en) 2001-04-04 2005-10-28 Alza Corp Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
AU2003280136A1 (en) * 2002-06-28 2004-01-19 Alza Corporation A reservoir for use in an electrotransport drug delivery device
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
WO2009002337A1 (en) * 2006-06-28 2008-12-31 Alza Corporation Methods and devices for transdermal electrotransport delivery of lofentanil and carfentanil
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
KR100730582B1 (ko) * 2006-11-20 2007-06-20 아람휴비스(주) 이온토포레시스 장치
US20080154230A1 (en) * 2006-12-20 2008-06-26 Janardhanan Anand Subramony Anode for electrotransport of cationic drug
US20090105634A1 (en) * 2007-10-17 2009-04-23 Alza Corporation Anodic Reservoir for Electrotransport of Cationic Drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride
WO2009123970A2 (en) * 2008-04-01 2009-10-08 Alza Corporation Electrotransport fentanyl delivery device with consistent delivery
EP2320885B1 (en) 2008-06-25 2016-10-19 Fe3 Medical, Inc Patches for the transdermal delivery of a therapeutically effective amount of iron
US20100004583A1 (en) * 2008-07-01 2010-01-07 Alza Corporation Hydrophobic Circuit Board Coating of Electrotransport Drug Delivery Devices
CA2735785C (en) * 2008-09-02 2015-01-27 Travanti Pharma Inc. Sacrificial electrode design and delivery species suitable for prolonged iontophoresis application periods
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2393549B1 (en) 2008-12-30 2014-10-01 NuPathe Inc. Electronic control of drug delivery system
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
WO2010107761A1 (en) 2009-03-18 2010-09-23 Acelrx Pharmaceuticals, Inc. Improved storage and dispensing devices for administration of oral transmucosal dosage forms
EP3103510A1 (en) * 2009-04-25 2016-12-14 Incube Labs, Llc System for transdermal iontophoretic delivery of chelated agents
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
AU2011239636A1 (en) 2010-04-13 2012-11-22 Najib Babul Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
WO2012071175A1 (en) 2010-11-23 2012-05-31 Nupathe, Inc. User-activated self-contained co-packaged iontophoretic drug delivery system
CN103826696B (zh) * 2011-03-24 2017-03-22 因卡伯实验室有限责任公司 用于治疗剂的两阶段经皮离子电渗递送的系统及方法
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
CA3120681C (en) 2012-04-17 2024-05-28 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
BR112017013311B1 (pt) 2014-12-23 2022-05-31 Acelrx Pharmaceuticals, Inc Aparelho para a dispensação de formas de dosagem via oral e transmucosal

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5135479A (en) 1983-08-18 1992-08-04 Drug Delivery Systems, Inc. Programmable control and mounting system for transdermal drug applicator
US5224928A (en) 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US5135477A (en) 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4752285B1 (en) 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) * 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US5006108A (en) 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5320597A (en) 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5232448A (en) 1989-12-05 1993-08-03 Prime Medical Products Patient-controlled analgesia device
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
IT1244030B (it) 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
ATE131392T1 (de) * 1990-03-30 1995-12-15 Alza Corp Gerät zur iontophoretischen verabreichung von medikamenten
US5125894A (en) * 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
US5224927A (en) 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US5254081A (en) 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
US5298017A (en) 1992-12-29 1994-03-29 Alza Corporation Layered electrotransport drug delivery system
US7027859B1 (en) * 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6216033B1 (en) * 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil

Also Published As

Publication number Publication date
IT1285387B1 (it) 1998-06-03
US20050171464A1 (en) 2005-08-04
JP4070779B2 (ja) 2008-04-02
KR19990022342A (ko) 1999-03-25
JP2005261970A (ja) 2005-09-29
GR960100178A (el) 1997-02-28
KR100431364B1 (ko) 2004-07-16
BR9609137B1 (pt) 2010-06-29
CH690751A5 (de) 2001-01-15
AU6257896A (en) 1996-12-24
CA2219736C (en) 2008-02-12
FR2736837A1 (fr) 1997-01-24
NL1003274C2 (nl) 1998-11-03
DE19681420B4 (de) 2009-05-28
WO1996039224A1 (en) 1996-12-12
BE1009505A3 (fr) 1997-04-01
DE19681420T1 (de) 1998-05-20
FR2736837B1 (fr) 1998-07-24
IE960374A1 (en) 1996-12-11
CA2613061C (en) 2010-02-09
ZA964658B (en) 1997-02-03
ITTO960477A0 (it) 1996-06-03
JP2007237002A (ja) 2007-09-20
US6881208B1 (en) 2005-04-19
CN1118308C (zh) 2003-08-20
SE9704103D0 (sv) 1997-11-10
SE521220C2 (sv) 2003-10-14
NL1003274A1 (nl) 1996-12-06
AT409088B (de) 2002-05-27
AU695465B2 (en) 1998-08-13
CA2219736A1 (en) 1996-12-12
ITTO960477A1 (it) 1997-12-03
JPH11506684A (ja) 1999-06-15
US20050131337A1 (en) 2005-06-16
GB2317115B (en) 1999-08-04
CA2613061A1 (en) 1996-12-12
ATA903696A (de) 2001-10-15
BR9609137A (pt) 1999-02-17
JP4616309B2 (ja) 2011-01-19
GB2317115A (en) 1998-03-18
GR1002982B (el) 1998-10-01
CN1187142A (zh) 1998-07-08
GB9725542D0 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
FI974418A0 (sv) Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil
SE9704103D0 (sv) Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil
SE9704102D0 (sv) Anordning för transdermal elektrotransporttillförsel av fentanyl och sufentanil
Lehmann et al. Transdermal fentanyl: clinical pharmacology
CA2650412C (en) Transdermal methods and systems for the delivery of anti-migraine compounds
KR100994631B1 (ko) 전리요법을 이용해 그라니세트론을 포함한 치료제를투약하기 위한 경피형 시스템
JPH07503232A (ja) メラトニンの制御経皮投与
NO920521D0 (no) Fremgangsmaate og anordning for administrering av deksmedetomidin transdermalt
EP1731152A3 (en) Sustained analgesia achieved with transdermal delivery of buprenorphine
PL326499A1 (en) Transcutateous therapeutic system (tts) for administration of active substances used in treating narcotic dependence or drug addiction
MX9709572A (es) Dispositivo para el suministro transdermico por electrotransporte de fentanilo y sufentanilo.
KR20000029523A (ko) 치매치료및(또는)예방용제제
Enck Transdermal narcotics for pain control
ATE185082T1 (de) Elektrisches gerät zur transdermalen verabreichung von medikamenten mit einem entgegenwirkenden produkt
AU2015203213B2 (en) Transdermal methods and systems for the delivery of anti-migraine compounds
AU2012261753A1 (en) Transdermal methods and systems for the delivery of anti-migraine compounds

Legal Events

Date Code Title Description
NUG Patent has lapsed